SEC Comment Letter 0000000000-25-003571 to Vigil Neuroscience, Inc. (VIGL) (CIK 0001827087)
Vigil Neuroscience, Inc. (VIGL) (CIK 0001827087)
Date: April 3, 2025 · CIK: 0001827087 · Accession: 0000000000-25-003571
AI Filing Summary & Sentiment
File numbers found in text: 333-286243
Letter
April 3, 2025 Ivana Magovevi-Liebisch, Ph.D., J.D. President and Chief Executive Officer Vigil Neuroscience, Inc. 100 Forge Road, Suite 700 Watertown, MA 02472 Re:Vigil Neuroscience, Inc. Registration Statement on Form S-3 Filed March 31, 2025 File No. 333-286243 Dear Ivana Magovevi-Liebisch Ph.D., J.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Gabriela Morales-Rivera, Esq.
Show Raw Text
April 3, 2025
Ivana Magovevi-Liebisch, Ph.D., J.D.
President and Chief Executive Officer
Vigil Neuroscience, Inc.
100 Forge Road, Suite 700
Watertown, MA 02472
Re:Vigil Neuroscience, Inc.
Registration Statement on Form S-3
Filed March 31, 2025
File No. 333-286243
Dear Ivana Magovevi-Liebisch Ph.D., J.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Gabriela Morales-Rivera, Esq.